CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Cytisine for Smoking Cessation: Clinical Effectiveness and Cost-Effectiveness

Last updated: September 18, 2017
Project Number: RB1136-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of cytisine for the treatment of smoking cessation?
  2. What is the cost-effectiveness of cytisine for the treatment of smoking cessation?

Key Message

One health technology assessment, four systematic reviews (including two with meta-analyses and one with an economic evaluation), and two randomized controlled trials were identified regarding the clinical effectiveness of cytisine for the treatment of smoking cessation.